Bukwang Pharmaceutical Co., Ltd. (KRX:003000)
South Korea
· Delayed Price · Currency is KRW 4,895.00
-50.00 (-1.01%)
Last updated: Mar 10, 2026, 1:26 PM KST
Bukwang Pharmaceutical Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 487,897 | 314,207 | 417,573 | 598,978 | 883,065 | 1,924,170 | Upgrade
|
| Market Cap Growth | 50.05% | -24.75% | -30.29% | -32.17% | -54.11% | 109.52% | Upgrade
|
| Enterprise Value | 350,991 | 280,401 | 368,683 | 519,044 | 826,852 | 1,868,498 | Upgrade
|
| Last Close Price | 4945.00 | 4109.78 | 5461.80 | 7834.55 | 11550.36 | 24970.20 | Upgrade
|
| PE Ratio | 37.87 | - | - | - | - | - | Upgrade
|
| Forward PE | - | 58.75 | 58.75 | 58.75 | 58.75 | 58.75 | Upgrade
|
| PS Ratio | 2.65 | 1.96 | 3.32 | 3.14 | 4.84 | 11.34 | Upgrade
|
| PB Ratio | 1.43 | 1.29 | 1.78 | 2.20 | 3.15 | 7.10 | Upgrade
|
| P/TBV Ratio | 1.47 | 1.32 | 1.93 | 2.34 | 3.36 | 7.65 | Upgrade
|
| P/FCF Ratio | 28.72 | 9.69 | - | 49.25 | 34.31 | - | Upgrade
|
| P/OCF Ratio | 21.62 | 9.14 | - | 36.39 | 33.29 | 2660.75 | Upgrade
|
| EV/Sales Ratio | 1.90 | 1.75 | 2.93 | 2.72 | 4.53 | 11.01 | Upgrade
|
| EV/EBITDA Ratio | 27.22 | 48.99 | - | 106.23 | 79.01 | 183.44 | Upgrade
|
| EV/EBIT Ratio | 45.76 | 173.34 | - | - | 147.08 | 463.86 | Upgrade
|
| EV/FCF Ratio | 20.66 | 8.65 | - | 42.67 | 32.12 | - | Upgrade
|
| Debt / Equity Ratio | 0.24 | 0.33 | 0.34 | 0.00 | 0.01 | 0.08 | Upgrade
|
| Debt / EBITDA Ratio | 6.09 | 13.88 | - | 0.19 | 0.15 | 2.12 | Upgrade
|
| Debt / FCF Ratio | 4.72 | 2.45 | - | 0.08 | 0.06 | - | Upgrade
|
| Net Debt / Equity Ratio | -0.40 | -0.21 | -0.31 | -0.31 | -0.29 | -0.25 | Upgrade
|
| Net Debt / EBITDA Ratio | -10.41 | -8.85 | 2.16 | -17.31 | -7.90 | -6.68 | Upgrade
|
| Net Debt / FCF Ratio | -8.08 | -1.56 | 5.89 | -6.95 | -3.21 | 56.98 | Upgrade
|
| Asset Turnover | 0.45 | 0.40 | 0.30 | 0.48 | 0.46 | 0.43 | Upgrade
|
| Inventory Turnover | 2.10 | 1.75 | 1.66 | 2.87 | 2.36 | 2.06 | Upgrade
|
| Quick Ratio | 3.71 | 4.37 | 1.93 | 3.90 | 4.79 | 3.16 | Upgrade
|
| Current Ratio | 4.60 | 5.76 | 2.61 | 4.90 | 5.95 | 4.06 | Upgrade
|
| Return on Equity (ROE) | 3.36% | -1.45% | -13.60% | -1.54% | -1.01% | -3.38% | Upgrade
|
| Return on Assets (ROA) | 1.21% | 0.25% | -5.65% | -0.04% | 0.88% | 0.64% | Upgrade
|
| Return on Invested Capital (ROIC) | 4.03% | 0.91% | -21.45% | -0.12% | -2.07% | 1.63% | Upgrade
|
| Return on Capital Employed (ROCE) | 2.00% | 0.50% | -11.30% | -0.10% | 1.60% | 1.20% | Upgrade
|
| Earnings Yield | 2.00% | -0.84% | -7.50% | -0.41% | -0.10% | -0.37% | Upgrade
|
| FCF Yield | 3.48% | 10.32% | -2.92% | 2.03% | 2.92% | -0.06% | Upgrade
|
| Buyback Yield / Dilution | -9.11% | - | - | 0.01% | 0.25% | 4.24% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.